Skip To Main Content
Amy Ying Xin on Muck Rack

Amy Ying Xin

As seen in: BMC Cancer, Neurology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amy Ying

Contact Amy Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial

|
By Amy Ying Xin, Philip Man Chiu, Timothy John
| Neurology Verified
Information & Authors Published In Neurology® Volume 106 • Number 9 • May 12, 2026 : e214925 Publication History Received: August 11, 2025 Accepted: February 20, 2026 Published online: April 14, 2026 Published in issue: May 12, 2026 Permissions Request permissions for this article.
Open in Who Shared Issue with article?

Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study | BMC Cancer | Full Text

|
By Nancy Noel, Amy Ying Xin
| BMC Cancer Verified
After exclusions, 3,461 patients were included in the study, of whom 473 (13.7%) received 50% and 2,988 (86.3%) received > 85% of a maximal course of oxaliplatin-containing adjuvant therapy (Fig. 1).
Open in Who Shared Issue with article?

A randomized controlled trial of tenecteplase versus standard of care for minor ischemic stroke with proven occlusion (TEMPO-2): rational and design of a multicenter, randomized open-label clinical trial

|
By Amy Ying Xin, Thalia Shoshana
| gla.ac.uk
Singh, N. et al. (2024) A randomized controlled trial of tenecteplase versus standard of care for minor ischemic stroke with proven occlusion (TEMPO-2): rational and design of a multicenter, randomized open-label clinical trial. International Journal of Stroke, (doi: 10.1177/17474930241253702) (PMID:38676572) (Early Online Publication) Text 325650.pdf - Published Version Available under License Creative Commons Attribution Non-commercial.
Open in Who Shared Issue with article?
See all 3 articles